Status:
COMPLETED
Intraoperative Phlebotomies and Bleeding in Liver Transplantation
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Liver Diseases
Liver Cirrhosis
Eligibility:
All Genders
Brief Summary
Liver transplantation are surgeries associated with important bleeding and often require perioperative red blood cell (RBC) transfusions. Overall, between 20 and 85 % of liver transplant recipients re...
Detailed Description
Methods Objective: To investigate the effects of intraoperative phlebotomies on intraoperative bleeding, perioperative transfusions and mortality among patients who underwent a liver transplantation....
Eligibility Criteria
Inclusion
- \- All successive adult patients who underwent a liver transplantation between July 2008 and January 2021 at the Centre hospitalier de l'Université de Montréal (CHUM).
Exclusion
- \- All patients who were under renal replacement therapy prior to surgery as well as those who had a glomerular filtration rate below 30 mL/h (based on MDRD formula).
Key Trial Info
Start Date :
March 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 4 2021
Estimated Enrollment :
679 Patients enrolled
Trial Details
Trial ID
NCT04826666
Start Date
March 31 2021
End Date
November 4 2021
Last Update
November 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada, H2X 3E4